JAG201
Pre-clinical- Indications
- Phelan-McDermid syndrome, SHANK3 haploinsufficiency
Company intelligence / Profile preview
Advanced Medicine Partners provides industry-leading process development, manufacturing, analytical development, and testing services for advanced medicines—especially viral vectors used in gene and cell therapies. Their proprietary AAV platform delivers high purity products with best-in-class functional full capsid ratios. The team has supported over 400 non-GMP batches and more than 20 preclinical studies including IND-enabling efficacy/toxicology work for clients. They are recognized for their operational experience from leading biotech companies such as Jaguar Gene Therapy, AveXis/Novartis, Amgen.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Medicine Partners.